This webinar will review the impact of the COVID-19 pandemic on lung cancer management and evaluate best practices for maintaining continuity of lung cancer care. The faculty panel will include a pulmonologist and medical oncologist who will discuss the key benefits of a multidisciplinary approach to the management of NSCLC and ES-SCLC and review recent treatment advances driven by targeted therapy and immunotherapy.